These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8284200)

  • 41. A single serine residue at position 375 of VP16 is critical for complex assembly with Oct-1 and HCF and is a target of phosphorylation by casein kinase II.
    O'Reilly D; Hanscombe O; O'Hare P
    EMBO J; 1997 May; 16(9):2420-30. PubMed ID: 9171355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concerted activity of host cell factor subregions in promoting stable VP16 complex assembly and preventing interference by the acidic activation domain.
    LaBoissière S; Walker S; O'Hare P
    Mol Cell Biol; 1997 Dec; 17(12):7108-18. PubMed ID: 9372942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recognition of the surface of a homeo domain protein.
    Pomerantz JL; Kristie TM; Sharp PA
    Genes Dev; 1992 Nov; 6(11):2047-57. PubMed ID: 1358755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential role for luman, the cellular homologue of herpes simplex virus VP16 (alpha gene trans-inducing factor), in herpesvirus latency.
    Lu R; Misra V
    J Virol; 2000 Jan; 74(2):934-43. PubMed ID: 10623756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The oct-1 homeo domain contacts only part of the octamer sequence and full oct-1 DNA-binding activity requires the POU-specific domain.
    Verrijzer CP; Kal AJ; van der Vliet PC
    Genes Dev; 1990 Nov; 4(11):1964-74. PubMed ID: 1980478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The herpes simplex virus VP16-induced complex: mechanisms of combinatorial transcriptional regulation.
    Herr W
    Cold Spring Harb Symp Quant Biol; 1998; 63():599-607. PubMed ID: 10384325
    [No Abstract]   [Full Text] [Related]  

  • 47. VP16 interacts via its activation domain with VP22, a tegument protein of herpes simplex virus, and is relocated to a novel macromolecular assembly in coexpressing cells.
    Elliott G; Mouzakitis G; O'Hare P
    J Virol; 1995 Dec; 69(12):7932-41. PubMed ID: 7494306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An activation domain in the C-terminal subunit of HCF-1 is important for transactivation by VP16 and LZIP.
    Luciano RL; Wilson AC
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13403-8. PubMed ID: 12271126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The POU domain of SCIP/Tst-1/Oct-6 is sufficient for activation of an acetylcholine receptor promoter.
    Fyodorov D; Deneris E
    Mol Cell Biol; 1996 Sep; 16(9):5004-14. PubMed ID: 8756659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A cellular factor binds to the herpes simplex virus type 1 transactivator Vmw65 and is required for Vmw65-dependent protein-DNA complex assembly with Oct-1.
    Xiao P; Capone JP
    Mol Cell Biol; 1990 Sep; 10(9):4974-7. PubMed ID: 2167442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural requirements in the herpes simplex virus type 1 transactivator Vmw65 for interaction with the cellular octamer-binding protein and target TAATGARAT sequences.
    Greaves RF; O'Hare P
    J Virol; 1990 Jun; 64(6):2716-24. PubMed ID: 2335815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The novel coactivator C1 (HCF) coordinates multiprotein enhancer formation and mediates transcription activation by GABP.
    Vogel JL; Kristie TM
    EMBO J; 2000 Feb; 19(4):683-90. PubMed ID: 10675337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential control of transcription by homologous homeodomain coregulators.
    Huang CC; Herr W
    Mol Cell Biol; 1996 Jun; 16(6):2967-76. PubMed ID: 8649408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Host factors associated with either VP16 or VP16-induced complex differentially affect HSV-1 lytic infection.
    Ding X; Neumann DM; Zhu L
    Rev Med Virol; 2022 Nov; 32(6):e2394. PubMed ID: 36069169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo.
    Sawtell NM; Triezenberg SJ; Thompson RL
    J Neurovirol; 2011 Dec; 17(6):546-51. PubMed ID: 22144074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of herpes simplex virus type 1 immediate-early gene expression by alpha interferon is not VP16 specific.
    Nicholl MJ; Preston CM
    J Virol; 1996 Sep; 70(9):6336-9. PubMed ID: 8709261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A sequence-specific DNA-binding protein recognising a GA-rich element cooperates with Oct-1 at the herpes simplex virus type 1 IE3 promoter.
    Bailey AC; Thompson R
    Intervirology; 1992; 34(2):74-85. PubMed ID: 1338062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Herpes simplex virus infections are arrested in Oct-1-deficient cells.
    Nogueira ML; Wang VE; Tantin D; Sharp PA; Kristie TM
    Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1473-8. PubMed ID: 14745036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A single amino acid substitution in herpes simplex virus type 1 VP16 inhibits binding to the virion host shutoff protein and is incompatible with virus growth.
    Knez J; Bilan PT; Capone JP
    J Virol; 2003 Mar; 77(5):2892-902. PubMed ID: 12584313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coactivator OBF-1 makes selective contacts with both the POU-specific domain and the POU homeodomain and acts as a molecular clamp on DNA.
    Sauter P; Matthias P
    Mol Cell Biol; 1998 Dec; 18(12):7397-409. PubMed ID: 9819426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.